Outcomes of AL-amyloidosis treatment with bortezomib, dexamethasone and cyclophosphamide or doxorubicin-containing regimens

According to the criteria for multiple myeloma, systemic AL-amyloidosis may be divided into primary systemic AL-amyloidosis, where monoclonal gametopathy is present but the criteria for multiple myeloma are not satisfied, and systemic AL-amyloidosis with underlying multiple myeloma. There is a conti...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Vnitřní lékar̆stvĭ 2012-12, Vol.58 (12), p.896-903
Hauptverfasser:	Adam, Z, Stork, M, Pour, L, Krejčí, M, Zahradová, L, Sandecká, V, Hájek, R, Cermáková, Z, Pospíšilová, Y, Navrátil, M, Král, Z, Mayer, J
Format:	Artikel
Sprache:	cze
Schlagworte:	Aged Amyloidosis - complications Amyloidosis - drug therapy Antineoplastic Combined Chemotherapy Protocols - therapeutic use Boronic Acids - administration & dosage Bortezomib Cyclophosphamide - administration & dosage Dexamethasone - administration & dosage Doxorubicin - administration & dosage Female Humans Male Multiple Myeloma - complications Pyrazines - administration & dosage
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!